{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:14:25Z","timestamp":1789773265767,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Hunan Province of China","award":["2023JJ40981"],"award-info":[{"award-number":["2023JJ40981"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72977-w","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T12:01:50Z","timestamp":1727524910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of disease activity in systemic lupus erythematosus using standard deviation of lymphocyte volume combined with red blood cell count and lymphocyte percentage"],"prefix":"10.1038","volume":"14","author":[{"given":"Juan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"72977_CR1","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/rheumatology\/keu482","volume":"54","author":"C Pamfil","year":"2015","unstructured":"Pamfil, C. et al. EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres. Rheumatology (Oxford)54, 1270\u20131278. https:\/\/doi.org\/10.1093\/rheumatology\/keu482 (2015).","journal-title":"Rheumatology (Oxford)"},{"key":"72977_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis, A. et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann. Rheum. Dis.78, 736\u2013745. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215089 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"72977_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/1756-185x.13817","volume":"23","author":"Y Tanaka","year":"2020","unstructured":"Tanaka, Y. State-of-the-art treatment of systemic lupus erythematosus. Int. J. Rheum. Dis.23, 465\u2013471. https:\/\/doi.org\/10.1111\/1756-185x.13817 (2020).","journal-title":"Int. J. Rheum. Dis."},{"key":"72977_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/14397595.2020.1775928","volume":"31","author":"K Ohmura","year":"2021","unstructured":"Ohmura, K. Which is the best SLE activity index for clinical trials? Mod. Rheumatol.31, 20\u201328. https:\/\/doi.org\/10.1080\/14397595.2020.1775928 (2021).","journal-title":"Mod. Rheumatol."},{"key":"72977_CR5","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1093\/rheumatology\/kead132","volume":"62","author":"A Onishi","year":"2023","unstructured":"Onishi, A. et al. Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes. Rheumatology (Oxford)62, 3909\u20133915. https:\/\/doi.org\/10.1093\/rheumatology\/kead132 (2023).","journal-title":"Rheumatology (Oxford)"},{"key":"72977_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/jbm.S95839","volume":"7","author":"N Arathi","year":"2016","unstructured":"Arathi, N., Sasidharan, P. K. & Geetha, P. Kozhikode criteria for diagnosing systemic lupus erythematosus as a hematological disorder. J. Blood Med.7, 13\u201318. https:\/\/doi.org\/10.2147\/jbm.S95839 (2016).","journal-title":"J. Blood Med."},{"key":"72977_CR7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.autrev.2013.02.001","volume":"12","author":"K Newman","year":"2013","unstructured":"Newman, K., Owlia, M. B., El-Hemaidi, I. & Akhtari, M. Management of immune cytopenias in patients with systemic lupus erythematosus - old and new. Autoimmun. Rev.12, 784\u2013791. https:\/\/doi.org\/10.1016\/j.autrev.2013.02.001 (2013).","journal-title":"Autoimmun. Rev."},{"key":"72977_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/labmed\/lmaa002","volume":"51","author":"A Peirovy","year":"2020","unstructured":"Peirovy, A. et al. Clinical usefulness of hematologic indices as predictive parameters for systemic lupus erythematosus. Lab. Med.51, 519\u2013528. https:\/\/doi.org\/10.1093\/labmed\/lmaa002 (2020).","journal-title":"Lab. Med."},{"key":"72977_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12016-017-8605-8","volume":"53","author":"A De Groof","year":"2017","unstructured":"De Groof, A. et al. Dysregulated lymphoid cell populations in mouse models of systemic lupus erythematosus. Clin. Rev. Allergy Immunol.53, 181\u2013197. https:\/\/doi.org\/10.1007\/s12016-017-8605-8 (2017).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"72977_CR10","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.semarthrit.2019.09.009","volume":"49","author":"M Aringer","year":"2019","unstructured":"Aringer, M. EULAR\/ACR classification criteria for SLE. Semin. Arthritis Rheum.49, S14\u2013s17. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.09.009 (2019).","journal-title":"Semin. Arthritis Rheum."},{"key":"72977_CR11","first-page":"69","volume":"24","author":"MM Mukaka","year":"2012","unstructured":"Mukaka, M. M. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med. J.24, 69\u201371 (2012).","journal-title":"Malawi Med. J."},{"key":"72977_CR12","doi-asserted-by":"publisher","first-page":"e22938","DOI":"10.7759\/cureus.22938","volume":"14","author":"JC Santacruz","year":"2022","unstructured":"Santacruz, J. C. et al. A practical perspective of the hematologic manifestations of systemic lupus erythematosus. Cureus14, e22938. https:\/\/doi.org\/10.7759\/cureus.22938 (2022).","journal-title":"Cureus"},{"key":"72977_CR13","first-page":"236","volume":"39","author":"A Aleem","year":"2014","unstructured":"Aleem, A., Al Arfaj, A. S., khalil, N. & Alarfaj, H. Haematological abnormalities in systemic lupus erythematosus. Acta Reumatol. Port39, 236\u2013241 (2014).","journal-title":"Acta Reumatol. Port"},{"key":"72977_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1159\/000511759","volume":"144","author":"A Klein","year":"2021","unstructured":"Klein, A. & Molad, Y. Hematological manifestations among patients with rheumatic diseases. Acta Haematol.144, 403\u2013412. https:\/\/doi.org\/10.1159\/000511759 (2021).","journal-title":"Acta Haematol."},{"key":"72977_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/1756-185x.12480","volume":"20","author":"WG Li","year":"2017","unstructured":"Li, W. G., Ye, Z. Z., Yin, Z. H. & Zhang, K. Clinical and immunological characteristics in 552 systemic lupus erythematosus patients in a southern Province of China. Int. J. Rheum. Dis.20, 68\u201375. https:\/\/doi.org\/10.1111\/1756-185x.12480 (2017).","journal-title":"Int. J. Rheum. Dis."},{"key":"72977_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/bf02229861","volume":"13","author":"C Osman","year":"1994","unstructured":"Osman, C. & Swaak, A. J. Lymphocytotoxic antibodies in SLE: a review of the literature. Clin. Rheumatol.13, 21\u201327. https:\/\/doi.org\/10.1007\/bf02229861 (1994).","journal-title":"Clin. Rheumatol."},{"key":"72977_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/qjmed\/hci155","volume":"99","author":"WL Ng","year":"2006","unstructured":"Ng, W. L., Chu, C. M., Wu, A. K., Cheng, V. C. & Yuen, K. Y. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. QJM99, 37\u201347. https:\/\/doi.org\/10.1093\/qjmed\/hci155 (2006).","journal-title":"QJM"},{"key":"72977_CR18","doi-asserted-by":"publisher","unstructured":"Li, C. et al. Antilymphocyte antibodies in systemic lupus erythematosus: association with disease activity and lymphopenia. J. Immunol. Res.2014 672126 (2014). https:\/\/doi.org\/10.1155\/2014\/672126","DOI":"10.1155\/2014\/672126"},{"key":"72977_CR19","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1177\/09612033221119455","volume":"31","author":"M Li","year":"2022","unstructured":"Li, M. et al. Elevated apoptosis and abnormal apoptosis signaling of regulatory T cells in patients with systemic lupus erythematosus. Lupus31, 1441\u20131455. https:\/\/doi.org\/10.1177\/09612033221119455 (2022).","journal-title":"Lupus"},{"key":"72977_CR20","doi-asserted-by":"publisher","first-page":"814857","DOI":"10.3389\/fimmu.2022.814857","volume":"13","author":"Z She","year":"2022","unstructured":"She, Z. et al. The role of B1 cells in systemic lupus erythematosus. Front. Immunol.13, 814857. https:\/\/doi.org\/10.3389\/fimmu.2022.814857 (2022).","journal-title":"Front. Immunol."},{"key":"72977_CR21","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s40744-022-00454-9","volume":"9","author":"SP Huang","year":"2022","unstructured":"Huang, S. P., Snedecor, S. J., Nanji, S., Lloyd, E. & Bell, C. F. Real-world effectiveness of belimumab in systemic lupus erythematosus: a systematic literature review. Rheumatol. Ther.9, 975\u2013991. https:\/\/doi.org\/10.1007\/s40744-022-00454-9 (2022).","journal-title":"Rheumatol. Ther."},{"key":"72977_CR22","doi-asserted-by":"publisher","first-page":"e32029","DOI":"10.1097\/md.0000000000032029","volume":"101","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. The effectiveness and safety of total glucosides of paeony in systemic lupus erythematosus: a systematic review and meta-analysis. Medine (Baltimore)101, e32029. https:\/\/doi.org\/10.1097\/md.0000000000032029 (2022).","journal-title":"Medine (Baltimore)"},{"key":"72977_CR23","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1093\/rheumatology\/keab217","volume":"60","author":"R Kandane-Rathnayake","year":"2021","unstructured":"Kandane-Rathnayake, R. et al. Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study. Rheumatology (Oxford)60, 5185\u20135193. https:\/\/doi.org\/10.1093\/rheumatology\/keab217 (2021).","journal-title":"Rheumatology (Oxford)"},{"key":"72977_CR24","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s10067-019-04873-y","volume":"39","author":"YF Chen","year":"2020","unstructured":"Chen, Y. F. et al. Inflammatory anemia may be an indicator for predicting disease activity and structural damage in Chinese patients with rheumatoid arthritis. Clin. Rheumatol.39, 1737\u20131745. https:\/\/doi.org\/10.1007\/s10067-019-04873-y (2020).","journal-title":"Clin. Rheumatol."},{"key":"72977_CR25","doi-asserted-by":"publisher","first-page":"100157","DOI":"10.1016\/j.jtauto.2022.100157","volume":"5","author":"V Moreno-Torres","year":"2022","unstructured":"Moreno-Torres, V. et al. Usefulness of the hemogram as a measure of clinical and serological activity in systemic lupus erythematosus. J. Transl. Autoimmun.5, 100157. https:\/\/doi.org\/10.1016\/j.jtauto.2022.100157 (2022).","journal-title":"J. Transl. Autoimmun."},{"key":"72977_CR26","doi-asserted-by":"publisher","first-page":"e22633","DOI":"10.1002\/jcla.22633","volume":"33","author":"J Yu","year":"2019","unstructured":"Yu, J. et al. Neutrophil-to-C3 ratio and neutrophil-to-lymphocyte ratio were associated with disease activity in patients with systemic lupus erythematosus. J. Clin. Lab. Anal.33, e22633. https:\/\/doi.org\/10.1002\/jcla.22633 (2019).","journal-title":"J. Clin. Lab. Anal."},{"key":"72977_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10238-020-00657-w","volume":"21","author":"Y Huang","year":"2021","unstructured":"Huang, Y. et al. Evaluation of systemic lupus erythematosus disease activity using anti-\u03b1-enolase antibody and RDW. Clin. Exp. Med.21, 73\u201378. https:\/\/doi.org\/10.1007\/s10238-020-00657-w (2021).","journal-title":"Clin. Exp. Med."},{"key":"72977_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.reuma.2018.07.008","volume":"16","author":"WM Soliman","year":"2020","unstructured":"Soliman, W. M., Sherif, N. M., Ghanima, I. M. & El-Badawy, M. A. Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: relation with disease activity and lupus nephritis. Reumatol. Clin. (Engl. Ed.). 16, 255\u2013261. https:\/\/doi.org\/10.1016\/j.reuma.2018.07.008 (2020).","journal-title":"Reumatol. Clin. (Engl Ed)"},{"key":"72977_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13075-019-2029-1","volume":"21","author":"N Ruchakorn","year":"2019","unstructured":"Ruchakorn, N. et al. Performance of cytokine models in predicting SLE activity. Arthritis Res. Ther.21, 287. https:\/\/doi.org\/10.1186\/s13075-019-2029-1 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"72977_CR30","doi-asserted-by":"publisher","unstructured":"Ayano, M. & Horiuchi, T. Complement as a biomarker for systemic lupus erythematosus. Biomolecules13https:\/\/doi.org\/10.3390\/biom13020367 (2023).","DOI":"10.3390\/biom13020367"},{"key":"72977_CR31","doi-asserted-by":"publisher","first-page":"110600","DOI":"10.1016\/j.clinbiochem.2023.110600","volume":"118","author":"JJ Huang","year":"2023","unstructured":"Huang, J. J., Mao, T. J., Zhang, Z. Y. & Feng, G. Systemic evaluation of lymphocyte-bound C4d and immunoglobulins for diagnosis and activity monitoring of systemic lupus erythematosus. Clin. Biochem.118, 110600. https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110600 (2023).","journal-title":"Clin. Biochem."},{"key":"72977_CR32","doi-asserted-by":"publisher","first-page":"102861","DOI":"10.1016\/j.jaut.2022.102861","volume":"132","author":"H Lou","year":"2022","unstructured":"Lou, H., Ling, G. S. & Cao, X. Autoantibodies in systemic lupus erythematosus: from immunopathology to therapeutic target. J. Autoimmun.132, 102861. https:\/\/doi.org\/10.1016\/j.jaut.2022.102861 (2022).","journal-title":"J. Autoimmun."},{"key":"72977_CR33","doi-asserted-by":"publisher","first-page":"102374","DOI":"10.1016\/j.jaut.2019.102374","volume":"110","author":"M Aringer","year":"2020","unstructured":"Aringer, M. Inflammatory markers in systemic lupus erythematosus. J. Autoimmun.110, 102374. https:\/\/doi.org\/10.1016\/j.jaut.2019.102374 (2020).","journal-title":"J. Autoimmun."},{"key":"72977_CR34","doi-asserted-by":"publisher","first-page":"e16798","DOI":"10.1097\/md.0000000000016798","volume":"98","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. The diagnostic values of C-reactive protein and procalcitonin in identifying systemic lupus erythematosus infection and disease activity. Medicine (Baltimore)98, e16798. https:\/\/doi.org\/10.1097\/md.0000000000016798 (2019).","journal-title":"Medicine (Baltimore)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72977-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72977-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72977-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T12:03:02Z","timestamp":1727524982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72977-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72977"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72977-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22470"}}